2. Alwall N, Lohi A: A population study on renal and urinary tract diseases. Acta Med Scand 1973; 194: 541-547
3. Chen BT, Ooi B-S, Tan K-K, et al: Comparative studies of asymptomatic proteinuria and hematuria. Arch Intern Med 1974; 134: 901-905
4. Levitt JI: The prognostic significance of proteinuria in young college students. Ann Intern Med 1967; 66(4): 685-696
5. Haug K, Bakke A, Daae LN, et al: Screening for hematuria, glucosuria and proteinuria in people aged 55-64. Scand J Prim Health Care 1985; 3: 31-34
6. Muth RG: Asymptomatic mild intermittent proteinuria. Arch Intern Med 1965; 115: 569-574
7. Phillippi PJ, Reynolds J, Yamauchi H, et al: Persistent proteinuria in asymptomatic individuals: renal biopsy studies on 50 patients. Mil Med 1966; 131: 1311-1317
8. Turnbull JM, Buck C: The value of perioperative screening investigations in otherwise healthy individuals. Arch Intern Med 1987; 147: 1101-1105
9. Johnson H Jr, Knee-Ioli S, Butler TA, et al: Are routine peroperative laboratory screening tests necessary to evaluate ambulatory surgical patients? Surgery 1988; 104(4): 639-645
10. Akin BV, Hubbell FA, Frye EB, et al: Efficacy of the routine admission urinalysis. Am J Med 1987; 82: 719-722
11. Del Mar C, Badger P: The place of routine urine testing on admission to hospital. Med J Aust 1989; 151: 151-153
12. Weiss R, Duckett J, Spitzer A: Results of a randomized control trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux. J Urol 1992; 148 (5 Pt 2): 1667-1673
13. King CH, Mahmoud AA: Drugs five years later: praziquantel. Ann Intern Med 1989; 110(4): 290-296
14. Brodehl J: The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 1991; 150(6): 380-387
15. Cameron JS: Membranous nephropathy and its treatment. Nephrol Dial Transplant 1992; 7: 72-79
16. Lewis EJ, Hunsicker LG, Bain RP, et al: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329(20): 1456-1462
17. Bjorck S, Mulec H, Johnson SA, et al: Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992; 304: 339-343
18. Parving H-H, Hommel E, Schmidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988; 297: 1086-1091
19. Hommel E, Parving H-H, Mathiesen E, et al: Effect of captopril on kidney function in insulin dependent diabetic patients with nephropathy. Br Med J Clin Res Ed 1986; 293: 467-470
20. Tuttle KR, Stein JH, DeFronzo RA: The natural history of diabetic nephropathy. Semin Nephrol 1990; 10(3): 184-193
21. Marre M, Chatellier G, Leblanc H, et al: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1989; 299: 230-33
22. Mogensen CE: Prevention and treatment of renal disease in insulin-dependent diabetes mellitus. Semin Nephrol 1990; 10: 260-273
23. Gurwitz JH, Bohn RL, Glynn RJ, et al: Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med 1993; 118: 273-278
24. Apperloo AJ, de Zeeuw D, Sluiter HE, et al: Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease. BMJ 1991; 303(6806): 821-824
25. Rodicio JL, Praga M, Alcazar JM, et al: Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans. J Hypertens Suppl 1989; 7(7): S43-S47
26. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: role of blood pressure. Kidney Int 1989; 35: 670-674
27. Rostand SG, Brown G, Kirk KA, et al: Renal insufficiency in treated essential hypertension. N Engl J Med 1989; 320: 684-688
28. Hartford M, Wendelhag I, Berglund G, et al: Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988; 259(17): 2553-2557
29. Weisstuch JM, Dworkin LD: Does essential hypertension cause end-stage renal disease? Kidney Int Suppl 1992; 36: S33-S37
30. Wolff FW, Lindeman RD: Effects of treatment in hypertension: Results of a controlled study. J Chronic Dis 1966; 19: 227-240
31. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on mobidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202: 1028-1034
32. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension II: Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143-1155
33. United States Public Health Service Hospitals Cooperative Study Group: Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res 1977; 40(5 Suppl I): I98-I105
34. Report by the Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261-1267
35. Amery A, Birkenhager W, Brixko P, et al: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 1: 1349-1354
36. Shulman NB, Ford CE, Hall WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Hypertension 1989; 13: I80-I93
37. Pettinger WA, Lee HC, Reisch J, et al: Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis. Hypertension 1989; 13: 766-772
38. Whelton PK, Klug MJ: Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension 1989; 13: I19-I27
39. Whelton PK: Declining mortality from hypertension and stroke. South Med J 1982; 75(1): 33-38
40. Fouque D, Laville M, Boissel JP, et al: Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ 1992; 304: 216-220
41. The Modification of Diet in Renal Disease Study Group: The modification of diet in renal disease study: design, methods and results from the feasibility study. Am J Kidney Dis 1992; 20(1): 18-33